Compare Novartis AG (NVS) vs Direxion Daily Semiconductor Bear 3X Shares (SOXS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novartis AG vs Direxion Daily Semiconductor Bear 3X Shares — how do they compare? Novartis AG trades at $142.86 (market cap $268.57B), while Direxion Daily Semiconductor Bear 3X Shares trades at $32.15 (market cap $1.96B). The key difference: Novartis AG is far larger — about 137× Direxion Daily Semiconductor Bear 3X Shares's market cap, and Novartis AG pays a 3.31% dividend while Direxion Daily Semiconductor Bear 3X Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Novartis AG for 82 Days and Direxion Daily Semiconductor Bear 3X Shares for 11 Days on average.
| NVS | SOXS | |
|---|---|---|
Market Cap | $268.57B | $1.96B |
Volume | 1,532,573 | 113,512,541 |
Sector | Health | Leveraged / Inverse |
52-Week High | $168.62 | $988.00 |
52-Week Low | $121.80 | $29.62 |
Typical Hold Time | 82 Days | 11 Days |
Enterprise Value | $309.89B | — |
Dividend Yield | 3.31% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Novartis (NVS) trades at $143.28, up 1.77% on the day, with a neutral technical signal and mixed earnings history. The company reported strong 2025 revenue of $56.67B and a net income margin of 22.5%, supported by a recent $7.8B licensing deal with China's Abogen. However, recent clinical trial setbacks and an ongoing law firm investigation introduce uncertainty.
The outlook is balanced; solid profitability and a consensus price target of $146.00 suggest modest upside, but risks from pipeline failures and heightened M&A scrutiny warrant caution. Investor sentiment is mixed, with analysts predominantly holding a neutral stance amid evolving business developments.
SOXS, the Direxion Daily Semiconductor Bear 3X ETF, trades at $30.645, up 3.43% today amid bearish technical signals. The ETF shows strong bearish momentum with moving averages indicating sell pressure, though oscillators are neutral. Recent news highlights SOXS as a tactical instrument for semiconductor sector declines, benefiting from AI stock volatility and chip sector weakness.
Outlook remains highly speculative given SOXS's inverse 3x leverage structure. Investment opportunity exists for short-term bearish semiconductor bets, but risks include extreme volatility, decay from daily reset, and persistent AI demand supporting chip stocks. This ETF is unsuitable for long-term holdings.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →About Direxion Daily Semiconductor Bear 3X Shares
SOXS is a leveraged ETF that seeks daily investment results corresponding to 300% of the inverse (opposite) of the daily performance of the ICE Semiconductor Index. It is designed as a tactical tool for experienced traders to take a bearish (short) position on the semiconductor sector. Due to the effects of compounding and leverage, SOXS is intended to be held for a single day and is not suitable for long-term investment.
Read more on SOXS →
